KORNITZER CAPITAL MANAGEMENT INC /KS
Position in VKTX — Viking Therapeutics, Inc.
CIK 898358
SHAWNEE MISSION, KS
Position in VKTX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$6,072,374
New position
Shares Held
155,662
first reported quarter
Ownership
0.133%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#64
of 432 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026KORNITZER CAPITAL MANAGEMENT INC /KS holds $91,599,609 across 23 Biotechnology names. VKTX ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
186,375 | $14,587,571 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
44,532 | $14,076,119 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
83,110 | $7,226,414 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
This page
|
155,662 | $6,072,374 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
199,683 | $5,235,688 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,124 | $5,154,837 | |
| 7 | VCEL |
Vericel Corp
|
113,127 | $5,033,020 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
13,126 | $4,878,540 |
All Filings in VKTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,072,374 | 155,662 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||